SE454301B - Forfarande for framstellning av tarmglukagonantigen och motsvarande antikropp - Google Patents

Forfarande for framstellning av tarmglukagonantigen och motsvarande antikropp

Info

Publication number
SE454301B
SE454301B SE8103198A SE8103198A SE454301B SE 454301 B SE454301 B SE 454301B SE 8103198 A SE8103198 A SE 8103198A SE 8103198 A SE8103198 A SE 8103198A SE 454301 B SE454301 B SE 454301B
Authority
SE
Sweden
Prior art keywords
asn
peptide
lys
antibody
arg
Prior art date
Application number
SE8103198A
Other languages
English (en)
Swedish (sv)
Other versions
SE8103198L (sv
Inventor
N Yanaihara
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE8103198L publication Critical patent/SE8103198L/xx
Publication of SE454301B publication Critical patent/SE454301B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/822—Identified hapten
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8103198A 1980-05-21 1981-05-20 Forfarande for framstellning av tarmglukagonantigen och motsvarande antikropp SE454301B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6804080A JPS56163456A (en) 1980-05-21 1980-05-21 Preparation of antigen

Publications (2)

Publication Number Publication Date
SE8103198L SE8103198L (sv) 1981-11-22
SE454301B true SE454301B (sv) 1988-04-18

Family

ID=13362282

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8103198A SE454301B (sv) 1980-05-21 1981-05-20 Forfarande for framstellning av tarmglukagonantigen och motsvarande antikropp

Country Status (8)

Country Link
US (1) US4407965A (esLanguage)
JP (1) JPS56163456A (esLanguage)
BE (1) BE888906A (esLanguage)
DE (1) DE3120312C2 (esLanguage)
DK (1) DK159163C (esLanguage)
FR (1) FR2482861A1 (esLanguage)
GB (1) GB2079289B (esLanguage)
SE (1) SE454301B (esLanguage)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1249395A (en) * 1982-09-30 1989-01-24 Tetsuya Tachikawa Human leukemia virus-related peptides, a process for production thereof, antibodies of the peptides and a process for production of the antibodies
CA1256795A (en) * 1983-12-28 1989-07-04 Dennis A. Carson Anti-idiotype antibodies induced by synthetic polypeptides
US4545985A (en) * 1984-01-26 1985-10-08 The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services Pseudomonas exotoxin conjugate immunotoxins
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
US5116725A (en) * 1984-08-08 1992-05-26 Scripps Clinic And Research Foundation Assay for Epstein-Barr virus infection with solid phase bound synthetic polypeptides
US4654419A (en) * 1984-08-08 1987-03-31 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
EP0196319B1 (en) * 1984-09-19 1992-01-02 The Regents Of The University Of California Retroviral polypeptides associated with human cellular transformation
US4732863A (en) * 1984-12-31 1988-03-22 University Of New Mexico PEG-modified antibody with reduced affinity for cell surface Fc receptors
JPH0792458B2 (ja) * 1986-03-14 1995-10-09 郁男 山科 糖鎖特異抗体アツセイプレ−ト及びその製造方法
US5202270A (en) * 1986-05-15 1993-04-13 Abbott Laboratories Cocaine and cocaine metabolites assay tracers, immunogens and antibodies
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
BR112017005110A2 (pt) 2014-09-16 2018-01-23 Regeneron Pharma anticorpo monoclonal isolado ou fragmento de ligação ao antígeno do mesmo, molécula isolada de ácido nucleico, composição farmacêutica, e, método para diminuir níveis de glicose no sangue ou para tratar uma condição ou doença.
CA3034777A1 (en) 2016-08-30 2018-03-08 Regeneron Pharmaceuticals, Inc. Methods of treating severe insulin resistance by interfering with glucagon receptor signaling
US20190248888A1 (en) 2016-10-20 2019-08-15 Regeneron Pharmaceuticals, Inc. Methods of lowering blood glucose levels
MX2020002057A (es) 2017-08-22 2020-07-13 Regeneron Pharma Metodos para tratar trastornos del ciclo de la urea mediante interferencia con la señalizacion del receptor del glucagon.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5836308B2 (ja) * 1977-02-10 1983-08-08 大塚製薬株式会社 抗体の製造方法
US4206199A (en) * 1977-07-22 1980-06-03 Takeda Chemical Industries, Ltd. Novel glucagon fragment and its derivatives

Also Published As

Publication number Publication date
SE8103198L (sv) 1981-11-22
DK159163B (da) 1990-09-10
JPS56163456A (en) 1981-12-16
FR2482861B1 (esLanguage) 1983-09-09
DK222081A (da) 1981-11-22
DE3120312A1 (de) 1982-03-04
DE3120312C2 (de) 1985-08-29
JPS6223822B2 (esLanguage) 1987-05-25
FR2482861A1 (fr) 1981-11-27
US4407965A (en) 1983-10-04
GB2079289B (en) 1983-10-26
BE888906A (fr) 1981-11-23
DK159163C (da) 1991-02-11
GB2079289A (en) 1982-01-20

Similar Documents

Publication Publication Date Title
US4474754A (en) Human interferon-related peptides, antigens, antibodies and process for preparing the same
SE454301B (sv) Forfarande for framstellning av tarmglukagonantigen och motsvarande antikropp
US4423034A (en) Process for the preparation of antibodies
US5854216A (en) Marker for growth hormone-releasing factor receptors
KR970009887B1 (ko) 심방의 나트륨이뇨성 펩티드의 선형유사체
US3953418A (en) Novel human proinsulin C-peptide derivatives
US4518527A (en) Polypeptides related to the pre-acetylcholine receptor-α of the electric organ of Torpedo californica
GB2062644A (en) Glucagon fragment and utility hereof
US20030186847A1 (en) Insulin derivatives and synthesis thereof
EP0257421A2 (en) Antibodies for use in determining human glycoalbumin
EP0009147A2 (en) A method for enzyme immunoassay of pancreatic glucagon and a peptide-enzyme conjugate usable for the method
Nachtmann et al. Oxytocin
Bandyopadhyay et al. Purification and properties of an Indian major carp (Cirrhinus mrigala, Ham.) pituitary thyrotropin
Katsoyannis et al. Insulin peptides. XXI. Synthesis of the B chain of sheep (bovine, porcine) insulin and its isolation as the S-sulfonated derivative
Ogawa et al. Effect of N‐methylation of selected peptide bonds on the biological activity of insulin.[2‐N‐Methylisoleucine‐A] insulin: [3‐N‐methylvaline‐A] insulin
US5446129A (en) Peptide or its salt for autoimmune hyperthyroidism containing it
JPH0453880B2 (esLanguage)
JPH0160780B2 (esLanguage)
JP2001226371A (ja) ダイオキシン誘導体およびこれを使用した測定法
JPS5830542B2 (ja) 抗体の製造法
EP0446797A2 (de) Synthetische Peptide, die Sequenzen aus Faktor VIIa enthalten und deren Verwendung
JPS6120560B2 (esLanguage)
JPS62281897A (ja) ペプチド類・抗体および測定法
JPH0224280B2 (esLanguage)
JPH0160038B2 (esLanguage)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8103198-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8103198-1

Format of ref document f/p: F